Mesothelioma screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (3 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Mesothelioma}} | {{Mesothelioma}} | ||
{{CMG}}{{AE}}{{PSD}} | {{CMG}}{{AE}}{{FA}}{{PSD}} | ||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend routine screening for mesothelioma. | There is insufficient evidence to recommend routine [[Screening (medicine)|screening]] for mesothelioma. | ||
== Screening == | == Screening == | ||
*There is no universally agreed protocol for screening people who have been exposed to asbestos. | *There is no universally agreed protocol for [[Screening (medicine)|screening]] people who have been exposed to [[asbestos]]. | ||
*However some research indicates that the [[osteopontin|serum osteopontin]] level might be useful in screening asbestos-exposed people for mesothelioma. | *However some research indicates that the [[osteopontin|serum osteopontin]] level might be useful in [[Screening (medicine)|screening]] [[asbestos]]-exposed people for mesothelioma. | ||
*The level of soluble mesothelin-related protein is elevated in the serum of about 75% of patients at diagnosis and it has been suggested that it may be useful for screening.<ref name="smrp">"Soluble mesothelin-related protein--a blood test for mesothelioma" by B. W. Robinson, J. Creaney, R. Lake, A. Nowak, A. W. Musk, N. de Klerk, P. Winzell, K. E. Hellstrom and I. Hellstrom in ''Lung Cancer'' (2005) volume 49, pages S109-S111 {{Entrez Pubmed|15950789}}.</ref> | *The level of soluble mesothelin-related protein is elevated in the [[serum]] of about 75% of patients at diagnosis and it has been suggested that it may be useful for [[Screening (medicine)|screening]].<ref name="smrp">"Soluble mesothelin-related protein--a blood test for mesothelioma" by B. W. Robinson, J. Creaney, R. Lake, A. Nowak, A. W. Musk, N. de Klerk, P. Winzell, K. E. Hellstrom and I. Hellstrom in ''Lung Cancer'' (2005) volume 49, pages S109-S111 {{Entrez Pubmed|15950789}}.</ref> | ||
==References== | ==References== | ||
| Line 20: | Line 20: | ||
[[Category:Asbestos]] | [[Category:Asbestos]] | ||
[[Category:Occupational diseases]] | [[Category:Occupational diseases]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
Latest revision as of 16:15, 25 April 2018
|
Mesothelioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Mesothelioma screening On the Web |
|
American Roentgen Ray Society Images of Mesothelioma screening |
|
Risk calculators and risk factors for Mesothelioma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Fatima Shaukat, MD [2]Parminder Dhingra, M.D. [3]
Overview
There is insufficient evidence to recommend routine screening for mesothelioma.
Screening
- There is no universally agreed protocol for screening people who have been exposed to asbestos.
- However some research indicates that the serum osteopontin level might be useful in screening asbestos-exposed people for mesothelioma.
- The level of soluble mesothelin-related protein is elevated in the serum of about 75% of patients at diagnosis and it has been suggested that it may be useful for screening.[1]
References
- ↑ "Soluble mesothelin-related protein--a blood test for mesothelioma" by B. W. Robinson, J. Creaney, R. Lake, A. Nowak, A. W. Musk, N. de Klerk, P. Winzell, K. E. Hellstrom and I. Hellstrom in Lung Cancer (2005) volume 49, pages S109-S111 Template:Entrez Pubmed.